Brief: Bacil Pharma Incorporates Wholly Owned Unit Bacil Research & Development
28/07/2026 16:32
BRIEF-Bacil Pharma Incorporates Wholly Owned Unit Bacil Research & Development July 28 (Reuters) - Bacil Pharma Ltd BACP.BO:
BACIL PHARMA - INCORPORATES WHOLLY OWNED SUBSIDIARY BACIL RESEARCH & DEVELOPMENT
Source text: ID:nBSE4xqw38
Further company coverage: BACP.BO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bacil Pharma
See all newsBrief: Bacil Pharma Incorporates Wholly Owned Unit Bacil Research & Development
Brief: Bacil Pharma Approves Rights Issue Of Equity Shares For Up To 500 Million Rupees
Brief: Bacil Pharma To Consider Rights Issue Of Equity Shares Up To 500 Million Rupees
Brief: Bacil Pharma Approves Fundraising Of Up To 500 Million Rupees
Brief: Bacil Pharma Says Board To Consider Fund Raising